Literature DB >> 8433277

Comparative evaluation of six rapid serological tests for HIV-1 antibody.

J D Malone1, E S Smith, J Sheffield, D Bigelow, K C Hyams, S G Beardsley, R S Lewis, C R Roberts.   

Abstract

Six commercial rapid test kits for HIV-1 antibody were evaluated. Four laboratory technologists tested sera from four groups of U.S. military personnel or dependents: 202 subjects positive for HIV-1 antibody by Western blot, 200 seronegative voluntary blood donors, 199 seronegative obstetrics/gynecology patients, and 99 subjects with sera reactive by ELISA but negative by recombinant protein EIA and indeterminate by Western blot. The three tests using solid-phase immunoassay technology demonstrated the highest mean sensitivity (> 99%) and specificity (> 91%) for all groups tested, including sera indeterminate by Western blot. Two dot-immunoblot assays were less specific, possibly due to indistinct reaction end points, and a latex agglutination assay was also less specific because of difficulty distinguishing reactive results from the granular background. In an "ease-of-use" assessment, solid-phase capture immunoassays required less time and equipment and were easier to interpret than other testing methods. Solid-phase capture immunoassays for HIV-1 antibody may be suitable for use in emergency situations and in developing countries because they are highly sensitive and specific and are rapidly performed with minimal laboratory equipment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8433277

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  11 in total

Review 1.  Detection of human immunodeficiency virus antibodies in oral fluids.

Authors:  R L Hodinka; T Nagashunmugam; D Malamud
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

2.  A simple whole-blood test for detecting antibodies to human immunodeficiency virus.

Authors:  W Schramm; S E Wade; G Barriga Angulo; P Castillo Torres; A Burgess-Cassler
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

3.  Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial.

Authors:  T S Alexander; L D Gray; J A Kraft; D S Leland; M T Nikaido; D H Willis
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Performance characteristics of a rapid new immunochromatographic test for detection of antibodies to human immunodeficiency virus.

Authors:  Rodrigo Ribeiro-Rodrigues; Lauro Ferreira da Silva Pinto Neto; Carla B Cunha; Valéria P Cabral; Reynaldo Dietze
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

Review 5.  Laboratory tests for detection of human immunodeficiency virus type 1 infection.

Authors:  N F Nuwayhid
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

6.  Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa.

Authors:  S Aidoo; W K Ampofo; J A Brandful; S V Nuvor; J K Ansah; N Nii-Trebi; J S Barnor; F Apeagyei; T Sata; D Ofori-Adjei; K Ishikawa
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

7.  Diagnosis of human immunodeficiency virus type 1 infection with different subtypes using rapid tests.

Authors:  S Phillips; T C Granade; C P Pau; D Candal; D J Hu; B S Parekh
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

8.  Field evaluation of the Determine rapid human immunodeficiency virus diagnostic test in Honduras and the Dominican Republic.

Authors:  C J Palmer; J M Dubon; E Koenig; E Perez; A Ager; D Jayaweera; R R Cuadrado; A Rivera; A Rubido; D A Palmer
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

9.  Urine samples as a possible alternative to serum for human immunodeficiency virus antibody screening.

Authors:  P Martínez; R O Lejarazu; J M Eiros; J D Benito; A Rodríguez-Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

10.  Alternative HIV testing methods among populations at high risk for HIV infection.

Authors:  Dawn R Greensides; Ruth Berkelman; Amy Lansky; Patrick S Sullivan
Journal:  Public Health Rep       Date:  2003 Nov-Dec       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.